⌕
10x Genomics · TXG · Nasdaq
Tenet 51 · Mixed
Compare
$54.99−5.50%At closeTenet 51 · Mixed
$54.99−3.20 (−5.50%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

10x Genomics (TXG) Key Ratios

Valuation, quality, health and growth. Every ratio ranked against its sector peers — the number we score — with its own ten-year record shown beside it for context.

Sources Company filings and market prices Filings and pricesRatios computed How we compute thisNot investment advice

23 figures withheld by our checks. Each blank figure names its reason.

16
VALUE
High multiples vs sector
premium price vs peers
48
QUALITY
Decent
mid-pack profitability
76
HEALTH
Sturdy
conservative balance sheet
65
GROWTH
FCF only
growth rates not measurable; scored on FCF margin alone

A decent business at high multiples for its sector: value 16, quality 48, health 76, growth 65, each a percentile within Healthcare.

Values are the trailing twelve months where a company files quarterly statements and the figure passes our check against the filings, with balance-sheet ratios from the most recent quarter; otherwise, or where a sector's figure is still under review, the latest fiscal year. Piotroski and the five-year growth rates are fiscal years. Each row names its period.track = where peers land, worse → better (direction-adjusted: right always means better)▏sector median● you are here▲ where today's value sits in the company's own ten fiscal years (context, not scored)hover any metric for its formula
16th pctilepremium price vs peers
Earnings yield (EBIT/EV)EBIT (operating income) for the latest fiscal year ÷ enterprise value on the current market cap (Greenblatt). The vendor's own earnings yield is net income to common ÷ market cap, a different figure.—Not reported in the company's filings for this period.
P/E—Not meaningful: the company made a loss.
P/B9.122nd pctile
P/FCF81.610th pctileown record too short
EV / EBITDA—Not meaningful: EBITDA is zero or negative.
76th pctileconservative balance sheet
Current ratio5.1271st pctile
Quick ratio(Cash, short-term investments and receivables) ÷ current liabilities, as the data vendor builds it. Its receivables include non-trade receivables, which Tenet's balance sheet shows inside other current assets.4.5271st pctile
Net debt / EBITDA(Total debt − cash) ÷ EBITDA—Not meaningful: EBITDA is zero or negative.
Interest coverage—Not meaningful: operating income is zero or negative.
Debt / equity0.0087th pctile
48th pctilemid-pack profitability
ROIC−9%37th pctile
ROE−8%40th pctile
Gross margin71.9%61st pctile
Net margin−10.8%28th pctile
Income quality (CFO/NI)—Not meaningful: the company made a loss.
Piotroski F4 / 933rd pctileown record too short
Altman Z19.491st pctile
65th pctilegrowth rates not measurable; scored on FCF margin alone
Revenue CAGRThe yearly rate that compounds the earliest fiscal year's revenue into the latest one, over the true number of fiscal years between them (up to five). When the earliest year's revenue is zero or negative, the rate starts from the first later year with at least $10M of revenue, provided at least three years remain.—This growth figure starts in a period outside the history your plan includes.
EPS CAGR—This growth figure starts in a period outside the history your plan includes.
FCF margin15.2%71st pctile
the receipts behind the numbers above
Greenblatt earnings yield—EBIT ÷ EV The vendor's "earningsYield" is NI ÷ market cap, which is not Greenblatt's formula.
ROIC−9%NOPAT ÷ invested capital The vendor's simple ROIC, not its tiny-base roic tag; withheld when a negative EBIT flips its sign.
Interest coverage— Guarded, not faked: we have no interest-expense figure on file for this company, so it's excluded from the ranking instead of rendered as garbage.
Percentiles computed nightly against 313 Healthcare peers from our ingested fundamentals DB · raw statements for corrected metrics. Direction-adjusted: for "lower is better" ratios (P/E, D/E…) the percentile is flipped so right always means better. The percentile is the stock's rank among sector peers, the number that is scored. The triangle marks where the current value (the trailing twelve months or the latest fiscal year, as its row names) sits in the company's own ten fiscal-year record, shown for context and never blended into the score. Computed Nov 13, 2026 · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.